Drug intelligence / Profile preview

An-Zi decoction

Development stage: Unknown
Lead developer: Shenzhen Maternal and Child Health Hospital
Administration: Oral

Overview

An-Zi decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by the Shenzhen Maternal and Child Health Center for the treatment of recurrent abortion (recurrent pregnancy loss). The therapy is based on the "Collaterals disease Theory" and employs the "Bu-Shen Huo-Xue" method, which focuses on tonifying the kidney and invigorating blood circulation to address underlying kidney deficiency and blood stasis believed to cause pregnancy loss. In clinical research, it is evaluated both as a monotherapy and in combination with low-molecular-weight heparin to improve pregnancy outcomes in women with a history of multiple miscarriages.

Other names: Anzi TangAn-Zi Tiao-Chong decoction

Beyond the preview

Go deeper on An-Zi decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on An-Zi decoction.

Explore the full profile